QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pharma-company-azitra-shoots-down-false-report-of-a-44m-stock-offering

Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision d...

 azitra-to-present-preclinical-progress-for-atr-01-program-targeting-treatment-of-ichthyosis-vulgaris-at-bio-europe-conference

ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgarisPreclin...

 azitra-doses-first-patient-in-phase-12-trial-of-atr04-484-for-egfri-associated-rash

Azitra, Inc. ("Azitra") (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therap...

 stock-market-today-dow-sp-500-futures-rise-as-wall-street-awaits-powells-jackson-hole-keynoteazitra-zoom-among-top-movers-updated

U.S. stock futures rose on Friday following Thursday's declines. Futures of major benchmark indices were higher.

 why-azitra-stock-shot-up-59-after-hours

Azitra shares surged over 58% after hours following a reverse stock split and new institutional ownership disclosure by Alumni ...

 azitra-executes-1-for-666-reverse-stock-split-effective-aug-21-common-shares-to-trade-on-adjusted-basis-following-shareholder-approved-amendment

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION